Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.070 | 1.000 | 7 | 2006 | 2018 | |||||
Malignant neoplasm of prostate
|
1082 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.070 | 0.714 | 7 | 2009 | 2019 | |||||
Prostate carcinoma
|
1168 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.070 | 0.714 | 7 | 2009 | 2019 | |||||
Breast Carcinoma
|
2793 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.060 | 1.000 | 6 | 2007 | 2017 | |||||
Ischemic stroke
|
704 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.060 | 0.833 | 6 | 2010 | 2019 | |||||
Malignant neoplasm of breast
|
3417 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.060 | 1.000 | 6 | 2007 | 2017 | |||||
Neoplasms
|
1644 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.050 | 1.000 | 5 | 2009 | 2017 | |||||
cervical cancer
|
268 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.040 | 1.000 | 4 | 2017 | 2018 | |||||
Cervix carcinoma
|
283 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.040 | 1.000 | 4 | 2017 | 2018 | |||||
Coronary Artery Disease
|
1577 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.040 | 1.000 | 4 | 2014 | 2019 | |||||
Malignant Neoplasms
|
1641 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.040 | 0.750 | 4 | 2007 | 2018 | |||||
Malignant tumor of cervix
|
245 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.040 | 1.000 | 4 | 2017 | 2018 | |||||
Primary malignant neoplasm
|
1374 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.040 | 0.750 | 4 | 2007 | 2018 | |||||
Tuberculosis
|
328 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.040 | 1.000 | 4 | 2018 | 2020 | |||||
Alzheimer's Disease
|
1843 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.720 | 1.000 | 3 | 2012 | 2016 | |||||
Central neuroblastoma
|
231 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.030 | 1.000 | 3 | 2009 | 2018 | |||||
Childhood Neuroblastoma
|
231 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.030 | 1.000 | 3 | 2009 | 2018 | |||||
Colorectal Carcinoma
|
1962 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.030 | 1.000 | 3 | 2007 | 2016 | |||||
Degenerative polyarthritis
|
247 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.030 | 1.000 | 3 | 2008 | 2014 | |||||
Depressive Symptoms
|
120 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.030 | 1.000 | 3 | 2010 | 2016 | |||||
Multiple Sclerosis
|
1022 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.030 | 1.000 | 3 | 2011 | 2018 | |||||
Neuroblastoma
|
386 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.030 | 1.000 | 3 | 2009 | 2018 | |||||
Schizophrenia
|
2897 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.030 | 1.000 | 3 | 2012 | 2018 | |||||
Acute GVH disease
|
49 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.020 | 1.000 | 2 | 2012 | 2018 | |||||
Adult Hodgkin Lymphoma
|
27 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.020 | 1.000 | 2 | 2013 | 2018 |